Charles Schwab Investment Management Inc. Sells 13,963 Shares of Aemetis, Inc. (NASDAQ:AMTX)

Charles Schwab Investment Management Inc. lowered its position in shares of Aemetis, Inc. (NASDAQ:AMTX) by 14.1% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 85,413 shares of the specialty chemicals company’s stock after selling 13,963 shares during the quarter. Charles Schwab Investment Management Inc. owned 0.18% of Aemetis worth $196,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Susquehanna Fundamental Investments LLC increased its position in shares of Aemetis by 287.4% during the second quarter. Susquehanna Fundamental Investments LLC now owns 126,078 shares of the specialty chemicals company’s stock valued at $379,000 after acquiring an additional 93,536 shares during the last quarter. Hutchinson Capital Management CA purchased a new stake in shares of Aemetis during the 2nd quarter valued at $70,000. Rhumbline Advisers raised its stake in shares of Aemetis by 2,837.1% during the 2nd quarter. Rhumbline Advisers now owns 52,309 shares of the specialty chemicals company’s stock worth $157,000 after purchasing an additional 50,528 shares during the period. Finally, Bank of New York Mellon Corp purchased a new position in shares of Aemetis in the 2nd quarter worth about $306,000. Hedge funds and other institutional investors own 27.02% of the company’s stock.

Analyst Upgrades and Downgrades

AMTX has been the subject of a number of research analyst reports. HC Wainwright restated a “buy” rating and set a $28.00 price objective on shares of Aemetis in a report on Friday, November 15th. Ascendiant Capital Markets decreased their price target on shares of Aemetis from $20.00 to $19.00 and set a “buy” rating for the company in a research note on Tuesday, September 3rd. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat, Aemetis currently has a consensus rating of “Moderate Buy” and an average price target of $12.95.

Aemetis Stock Performance

Shares of Aemetis stock opened at $2.69 on Friday. The stock has a market capitalization of $133.79 million, a P/E ratio of -1.19 and a beta of 1.35. Aemetis, Inc. has a 52-week low of $2.10 and a 52-week high of $7.03. The stock’s 50-day simple moving average is $3.30 and its 200 day simple moving average is $3.01.

Aemetis (NASDAQ:AMTX) last posted its quarterly earnings results on Tuesday, November 12th. The specialty chemicals company reported ($0.38) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.47) by $0.09. The business had revenue of $81.44 million during the quarter, compared to the consensus estimate of $77.79 million. During the same period last year, the firm earned ($0.59) EPS. Equities research analysts forecast that Aemetis, Inc. will post -2.02 EPS for the current fiscal year.

Aemetis Company Profile

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.